New hope for painful mouth sores: drug trial targets Behçet's ulcers
NCT ID NCT05449548
First seen Oct 31, 2025 · Last updated May 13, 2026 · Updated 28 times
Summary
This study tests whether the drug lenalidomide can safely heal mouth ulcers in adults with a rare condition called mucosal Behçet's syndrome. About 42 participants will take the drug for 12 weeks to see if their ulcers disappear or become fewer. The goal is to control the disease and ease symptoms, not to cure it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ORAL ULCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Peking Union Medical College Hospital
RECRUITINGBeijing, Beijing Municipality, 100730, China
Contact
Contact
Conditions
Explore the condition pages connected to this study.